Last updated: April 23, 2026
Which manufacturers supply mannitol 5% injection in plastic containers?
Mannitol 5% injection (typically “mannitol 5% in water for injection”) is commonly supplied as a sterile solution in plastic infusion containers such as flexible plastic bags (e.g., VIAFLEX-style systems) or other plastic containers. Supplier lists below reflect established global manufacturers that sell mannitol injection and/or mannitol injection presentations in plastic containers through regulated channels.
Global manufacturers (brand or authorized generics)
| Company |
Typical product scope |
Container formats seen in market |
| Baxter International |
Sterile injectables and infusion solutions |
Flexible plastic bags; regulated infusion container systems |
| Fresenius Kabi |
Injectable fluids and infusion solutions |
Plastic infusion containers used for mannitol products in multiple markets |
| B. Braun |
Parenteral solutions |
Plastic infusion container systems; distribution varies by country |
| Sandoz (Novartis) |
Generic sterile injectables |
Plastic container presentations in regulated markets |
| Hikma / local partners |
Generic sterile products |
Plastic container presentations via authorized distributors |
| Otsuka / portfolio partners |
Injectable and infusion solutions in certain markets |
Plastic container formats depending on local registration |
| Incepta / limited markets |
Generics including infusion solutions |
Plastic container presentations in local/regional supply chains |
| Indian generic manufacturers (varies by dossier holder) |
Mannitol injection supply for specific markets |
Plastic container presentations depending on registration |
Note on “plastic container”: Many mannitol 5% injections are sold in flexible bags; listings depend on the specific national registration, pack size, and container design. Supplier identity changes by geography and tender requirements.
What supply-chain routes are used for mannitol 5% in plastic containers?
For regulated procurement, suppliers typically enter supply via one of two routes:
1) Direct manufacturer distribution (Baxter, Fresenius Kabi, B. Braun, Sandoz) to wholesalers, hospital networks, and tenders
2) Authorized generic distributors / regional marketing authorization holders (common for multi-country generic access)
Common tender-ready documentation includes:
- Product registration number in the destination country
- Certificates of Analysis (CoA) per lot
- Compliance with pharmacopeial standards for mannitol and parenteral solution requirements
- Container system compliance (sterile, integrity, and compatibility for infusion)
What container and presentation specs typically govern supplier eligibility?
Supplier selection for “mannitol 5% in plastic container” is driven by container-system match and sterile presentation:
Container system (typical)
- Flexible plastic infusion bag (common for 5% mannitol solutions)
- Alternative plastic rigid containers or unit-dose plastic formats in some markets
Key product attributes used in qualification
- Sterility assurance (sterile injectable)
- Route: parenteral infusion
- Concentration: 5% w/v mannitol
- Water-for-injection grade and formulation consistency
- Storage and handling conditions per local labeling
Which countries are most likely to have multiple supplier options in plastic containers?
Mannitol injection is widely manufactured, and competition increases where hospital formularies source through international and local tender systems. Multiple supplier options usually exist in:
- EU and UK (Baxter, Fresenius Kabi, B. Braun and generics)
- US and Canada (manufacturer-controlled portfolios plus authorized generics depending on market cycle)
- Middle East and North Africa (multi-manufacturer access through authorized agents)
- Latin America and parts of Asia (local registration-driven sourcing)
What information procurement teams should map to supplier offers (to avoid pack mismatch)?
Because “plastic container” is not a single SKU globally, procurement typically aligns offers against the following:
- Container type (flexible bag vs rigid plastic vs unit-dose)
- Pack size (commonly 250 mL, 500 mL, 1000 mL, varies by country)
- Labeling language and local registration (country-specific)
- Strength and formulation (mannitol 5% only, and whether any additional excipients exist)
- Regulatory status (market authorization holder and manufacturing site)
Where do these suppliers publish their sterile infusion/manntiol portfolios?
Major suppliers publish regulated product catalogs through:
- Company sterile injectables and hospital infusion solution catalogs
- National product listings tied to marketing authorizations
- Hospital tender catalogs and distributor listings
Key Takeaways
- Baxter, Fresenius Kabi, and B. Braun are among the most consistent global suppliers for sterile infusion solutions and mannitol presentations sold in plastic infusion containers in regulated markets.
- Sandoz and other generic players supply mannitol injection through local marketing authorizations; plastic container match depends on destination-country registration and pack size.
- Supplier qualification must align on container type, pack size, and local registration, not only on “mannitol 5%”.
FAQs
1) Is “mannitol 5% in plastic container” always a flexible bag?
No. Plastic-container presentations often use flexible infusion bags, but some markets use different plastic formats. Exact container type is registration and pack dependent.
2) Do the same suppliers offer mannitol 5% in all countries?
No. Availability depends on local approvals, tenders, and distributor networks. Large global manufacturers typically cover many markets but not every market at all times.
3) Which differentiates suppliers for hospital procurement?
Container format, pack size, local registration details, supply continuity, and lot-level documentation (CoA and container integrity/sterility data).
4) Can generic mannitol 5% substitute for branded products in plastic containers?
In principle, yes if the generic has the same registered strength and formulation and meets the destination-country regulatory requirements, including container compatibility and sterile presentation.
5) What drives price and lead time for mannitol 5% plastic container supply?
Tender schedules, container system availability, manufacturing site allocation, and regulatory lot release timelines in the destination country.
References
[1] Baxter International Inc. Product information and hospital infusion solutions catalog. Baxter website (retrieved 2026-04-24).
[2] Fresenius Kabi. Injectable and infusion portfolio listings (including mannitol injection presentations). Fresenius Kabi website (retrieved 2026-04-24).
[3] B. Braun. Parenteral solutions and infusion products (including mannitol injection) by market. B. Braun website (retrieved 2026-04-24).
[4] Sandoz. Generic injectable products portfolio and market listings. Sandoz website (retrieved 2026-04-24).
